Browse by all authors Browse By Author Name - Pericak,+D.

Browse Results (17 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Raynauld, J. P., Bellamy, N., Goldsmith, C. H., Tugwell, P., Torrance, G.W., Pericak, D., Band, P., Polisson, R. and Belovich, D. (2002). An evaluation of the safety and effectiveness of repeat courses of hylan G-F 20 for treating patients with knee osteoarthritis. In: R. D. Altman, 7th World Congress of the OsteoArthritis Research Society International, Osteoarthritis & Cartilage. Osteoarthritis & Cartilage. 7th World Congress of the OsteoArthritis Research Society International, Sydney, (S63-S63). 25-28 Sept, 2002. 70  
Torrance, G.W., Bellamy, N., Raynauld, J. P., Goldsmith, C. H., Tugwell, P., Polisson, R., Belovich, D., Pericak, D. and Gough, J. (2002). A prospective, randomized controlled trial evaluating the effectiveness and safety of hylan G-F 20 in patients with knee osteoarthritis: six month clinical results of a single course of treatment. In: R. D. Altman, 7th World Congress of the OsteoArthritis Research Society International, Osteoarthritis & Cartilage. Osteoarthritis & Cartilage. 7th World Congress of the OsteoArthritis Research Society International, Sydney, (S63-S63). 25-28 Sept, 2002. 191  
Raynauld, J. P., Bellamy, N., Goldsmith, C. H., Tugwell, P., Torrance, G. W., Walker, V., Schultz, M., Pericak, D. and Band, P. (2000). A prospective randomized health outcomes trial of hylan G-F 20 in the treatment of patients with knee osteoarthritis. In: D.S. Pisetsky, Arthritis & Rheumatism Abstract Supplement. 2000 Annual Scientific Meeting, ACR, Philadelphia, (S340-S340). 28 Oct - 02 Nov, 2000. 84  
Bellamy, N., Bell, M. J., Pericak, D., Goldsmith, C. H., Torrance, G. W., Raynauld, J. P., Walker, V., Tugwell, P. and Polisson, R. (2007) BLISS index for analyzing knee osteoarthritis trials data. Journal of Clinical Epidemiology, 60 2: 124-132. doi:10.1016/j.jclinepi.2006.04.004 62   9 Cited 10 times in Scopus10 0
Raynauld, J. P., Olszynski, W. P., Goldsmith, C. H., Torrance, G.W., Bellamy, N., Polisson, R., Pericak, D. and Walker, V. (2003). Effectiveness and safety of Hylan G-F 20 compared to steroid injections in patients with knee osteoarthritis. In: D. Pisetsky, ACR/ARHP Poster Session C. American College of Rheumatology 2003 Annual Scientific Meetig, Orlando, Florida, (S484-S484). 23-28 Oct, 2003. 76  
Raynauld, J. P., Goldsmith, C. H., Torrance, G.W., Polisson, R., Bellamy, N., Pericak, D. and Walker, V. (2003). Effectiveness and safety of hylan G-F 20 compared to steroid injections in patients with knee osteoarthritis. In: R. D. Altman, Poster Session. 8th World Congress of the OsteoArthritis Research Society Int, Berlin, Germany, (S120-S120). 12-15 Oct, 2003. 69  
Raynauld, J. P., Goldsmith, C. H., Bellamy, N., Torrance, G. W., Polisson, R., Belovich, D., Pericak, D. and Tugwell, P. (2005) Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Osteoarthritis And Cartilage, 13 2: 111-119. doi:10.1016/j.joca.2004.10.018 92   20 Cited 26 times in Scopus26 0
Bell, M. J., Bellamy, N., Goldsmith, C. H., Tugwell, P., Torrance, G.W., Raynauld, J-P., Polisson, R., Pericak, D. and Walker, V. (2003). Evaluation of the OARSI and OMERACT-OARSI set of responder criteria in patients treated with hylan G-F 20 for knee osteoarthritis. In: D. Pisetsky, ACR/ARHP Poster Session C. American College of Rheumatology 2003 Annual Scientific Meetig, Orlando, Florida, (S482-S482). 23-28 Oct, 2003. 101  
Bellamy, N., Bell, M. J., Goldsmith, C. H., Tugwell, P., Torrance, G.W., Raynauld, J. P., Polisson, R., Pericak, D. and Walker, V. (2003). Evaluation of the OARSI and OMERACT-OARSI sets of responder criteria in patients treated with hylan G-F 20 for knee osteoarthritis. In: R. D. Altman, Poster Session. 8th World Congress of the OsteoArthritis Research Society Int, Berlin, Germany, (S80-S80). 12-15 Oct, 2003. 162  
Bellamy, N., Bell, M. J., Goldsmith, C. H., Pericak, D., Walker, V., Raynauld, J. P., Torrance, G. W., Tugwell, P. and Polisson, R. (2005) Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis. Annals of The Rheumatic Diseases, 64 6: 881-885. doi:10.1136/ard.2004.026443 98   22 Cited 21 times in Scopus21 0
Bellamy, N., Bell, M. J., Goldsmith, C. H., Torrance, G.W., Raynauld, J., Tugwell, P., Polisson, R., Pericak, D. and Walker, V. (2004). Examining minimal perceptible clinical improvement criteria in patients treated with hylan G-F-20 for knee osteoarthritis. In: L. van de Putte, Osteoarthritis - Clinical aspects and treatment. Anneual European Congress of Rheumatology EULAR, Berlin, (357-357). 9-12 Jun, 2004. 102   0
Goldsmith, C. H., Bellamy, N., Pericak, D., Torrance, G. W., Raynauld, J. P., Bell, M. and Polisson, R. (2004). Predictors of osteoarthritis(OA) improvement in patients treated with Hylan G-F for knee OA.. In: R. D. Altman, Osteoarthritis & Cartilage. 9th World Congress of Osteoarthritis Res. Soc. Int., Chicago, (S77-S77). 2-5 December, 2004. doi:10.1016/j.joca.2004.09.004 92   0 0
Bellamy, N., Bell, M. J., Pericak, D., Goldsmith, C. H., Torrance, G. W., Raynauld, J. P., Walker, V., Tugwell, P. and Polisson, R. (2006). Preliminary investigation of the discriminatory capacity of measures of low intensity symptom state-attainment using the WOMAC Pain Subscale score in patients treated with hylan G-F 20 for knee osteoarthritis. In: Value Health: Abstracts of ISPOR 11th Annual International Meeting. ISPOR 11th Annual International Meeting, Marriott, PA, (A28-A29). 20-24 May 2006. doi:10.1111/j.1524-4733.2006.00102_2.x 60   3
Bellamy, N., Bell, M. J., Goldsmith, C. H., Tugwell, P., Torrance, G.W., Raynauld, J. P., Polisson, R., Pericak, D. and Walker, V. (2003). Symptom free response using the WOMAC pain score in patients treated with hylan G-F 20 for knee osteoarthritis. In: R. D. Altman, Poster Session. 8th World Congress of the OsteoArthritis Research Society Int, Berlin, Germany, (S42-S42). 12-15 Oct, 2003. 107  
Bellamy, N, Bell, MJ, Goldsmith, CH, Pericak, D, Walker, V, Raynauld, JP, Torrance, GW, Tugwell, P and Polisson, R (2005) The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI. Osteoarthritis And Cartilage, 13 2: 104-110. doi:10.1016/j.joca.2004.10.016 63   19 Cited 20 times in Scopus20 0
Bellamy, N., Bell, M. J., Goldsmith, C. H., Tugwell, P., Torrance, G.W., Raynauld, J. P., Polisson, R., Pericak, D. and Walker, V. (2003). WOMAC 20, 50, 70 response levels in patients treated with hylan G-F 20 for knee osteoarthritis. In: R. D. Altman, Poster Session. 8th World Congress of the OsteoArthritis Research Society Int, Berlin, Germany, (S82-S82). 12-15 Oct, 2003. 37  
Bellamy, N., Bell, M. J., Goldsmith, C. H., Torrance, G.W., Raynauld, J., Tugwell, P., Polisson, R., Pericak, D. and Walker, V. (2004). WOMAC 20, 50 70 response levels in patients treated with hylan G-F 20 for knee osteoarthritis. In: L. van de Putte, Osteoarthritis - Clinical aspects and treatment. Anneual European Congress of Rheumatology EULAR, Berlin, (359-359). 9-12 Jun, 2004. 48   1